Skip to main content

Table 3 Effect of Matrine salvianolic acid B salt on HA, LN and Hyp in rats

From: Hepatoprotective effect of Matrine salvianolic acid B salt on Carbon Tetrachloride-Induced Hepatic Fibrosis

Treatment Doses
(mg/kg)
HA (ng/ml) LN (ng/ml) HyP (ng/ml)
Normal control —— 213.46 ± 21.62 85.39 ± 3.98 16.38 ± 1.30
CCl4 —— 328.71 ± 18.42## 109.93 ± 18.16## 32.34 ± 6.41##
Matrine+ CCl4 50 292.49 ± 30.73* 94.79 ± 19.24* 27.14 ± 1.58**
Salvianolic acid B+ CCl4 150 290.66 ± 53.77* 88.36 ± 19.44** 22.25 ± 1.88**
  25 289.88 ± 27.00* 99.79 ± 23.42 19.71 ± 1.52**bc
Matrine salvianolic acid B Salt+ CCl4 50 276.77 ± 47.19** 85.61 ± 14.21** 19.14 ± 1.86**bd
  100 264.70 ± 49.62** 81.61 ± 16.22**a 18.65 ± 1.94**bd
Fu fang bie jia ruan gan pian+ CCl4 780 299.76 ± 33.99 97.37 ± 15.35* 18.86 ± 1.79**
  1. Data is expressed as the mean±SD (n = 12).
  2. ##p < 0.01 vs. the normal control group; *p < 0.05, **p < 0.01 vs. the CCl4-treated group;
  3. ap < 0.05, bp < 0.01 vs. the Matrine group; cp < 0.05, dp < 0.01 vs. the Salvianolic acid B group.